What Epic Pharma does

Epic Pharma is a privately held U.S. generic pharmaceutical manufacturer that develops, produces, and distributes FDA-approved generic prescription medications. Founded in 2008 after acquiring the former Sandoz manufacturing facility in Laurelton, New York, the company operates from a single 110,000 square foot cGMP-compliant facility that is both FDA-approved and DEA-licensed, enabling it to manufacture controlled substances across Schedules II through V. The company's product portfolio encompasses more than 50 generic medications across cardiovascular, central nervous system, anti-infective, respiratory, and controlled-substance therapeutic categories, including generic equivalents of branded products such as Adderall, Percocet, Zithromax, Tamiflu, Methadone, and Wellbutrin XL. Manufacturing capabilities span oral solid dosage forms (tablets, capsules, powders) as the core focus, with extended capabilities in injectables, ophthalmics, nasal sprays, and softgelatin capsules. The technical infrastructure includes in-house analytical testing (HPLC, GC, IR, UV, automated dissolution, SEM), validated processing equipment (granulators, fluid bed dryers, instrumented tablet presses, capsule fillers, coaters), full DSCSA-compliant serialization with unit/case/pallet EPCIS aggregation, and EDI integration across transaction sets 844, 845, 849, 852, and 867.

Epic Pharma generates revenue through two streams: (1) sale of FDA-approved generic medications to U.S. healthcare providers, pharmacies, and wholesalers via domestic distribution channels, and (2) contract manufacturing services for external pharmaceutical partners requiring cGMP-compliant production capacity. The company pursues a sales-led B2B go-to-market model with no consumer-facing marketing, relying on its corporate website, LinkedIn presence, and direct industry engagement for customer acquisition. CEO Xiaofeng Meng leads the organization, which has 101–250 employees. The company is incorporated as Epic Pharma LLC in New York, USA, with no disclosed parent company, institutional investors, or venture capital backing.

The company's strategic posture is that of a stable, mid-sized generic manufacturer with a broad therapeutic footprint and controlled-substance capability. Documented product launches span January 2016 through April 2019, after which no new product launches appear in the input data — a six-year gap that represents a notable signal. The business model combines organic product development (including branded-generic entries such as KLAYESTA) with contract manufacturing leverage of existing capacity, all under a single-site operating model with U.S.-only geographic exposure.

Name

Epic Pharma

Legal name

Epic Pharma LLC

Website

https://epic-pharma.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

101–250 employees

Short description

Epic Pharma is a privately held U.S. generic pharmaceutical manufacturer that develops and distributes FDA-approved generic medications across cardiovascular, CNS, anti-infective, respiratory, and controlled substance categories from its 110,000 sq ft cGMP-compliant facility in Laurelton, New York.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)

Keywords

• Generic pharmaceuticals
• Oral solid dosage
• Contract manufacturing
• Controlled substances
• CGMP manufacturing

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Generic Pharmaceutical Sales: Sale of FDA-approved generic medications across therapeutic categories including cardiovascular, CNS, anti-infectives, respiratory, and controlled substances. Revenue generated through distribution to healthcare providers, pharmacies, and wholesalers.
2. Contract Manufacturing Services: Provides contract manufacturing services to external partners, offering end-to-end capabilities from R&D to production, maintaining strict process controls and regulatory compliance for scalable production.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Epic Pharma develops, manufactures, and distributes generic prescription medications in tablet, capsule, and powder forms across therapeutic categories including Cardiovascular, CNS, Anti-infectives, Respiratory, and Controlled Substances (Schedule II-V) from its FDA-approved, cGMP-compliant facility in Laurelton, NY. The company also provides contract manufacturing services for pharmaceutical partners using its registered facility and analytical capabilities.

Product overview

Epic Pharma is an FDA-approved generic pharmaceutical company that develops, manufactures, and distributes high-quality generic medications. The company operates a 110,000 square foot cGMP-compliant facility in Laurelton, NY, specializing in oral solid dosage medications (tablets, capsules, powders) since 2008, with additional capabilities in injectables, ophthalmic, nasal spray, and softgelatin capsules. The product portfolio includes FDA-approved generic medications across multiple therapeutic areas: Cardiovascular (Amlodipine Besylate, Metoprolol Succinate, Sotalol, Flecainide Acetate, Icosapent Ethyl, Omega-3-Acid, Nicardipine), CNS/Behavioral Health (Bupropion, Carbamazepine, Estradiol, Gabapentin, Guanfacine, Hydroxyzine, Protriptyline, Venlafaxine, BusPIRone, Dextroamphetamine/Amphetamine, Molindone), Anti-infectives (Azithromycin, Doxycycline, Ethambutol, Rifampin, Sulfadiazine), Respiratory (Benzonatate), and Controlled Substances (CII-CV). The company offers both internal drug development and contract manufacturing services to partners.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic Cardiovascular Pharmaceuticals Generic prescription medications for cardiovascular conditions, manufactured in oral solid dosage forms (tablets, capsules, powders) at the Laurelton, NY facility.
• Generic CNS Pharmaceuticals Generic central nervous system prescription medications manufactured in oral solid dosage forms.
• Generic Anti-infective Pharmaceuticals Generic anti-infective prescription medications manufactured in oral solid dosage forms.
• Generic Respiratory Pharmaceuticals Generic respiratory prescription medications manufactured in oral solid dosage forms.
• Generic Controlled Substances (Schedule II-V) Generic controlled substance medications across DEA Schedules II through V, manufactured with DEA-registered handling and full regulatory compliance.
• Pharmaceutical Contract Manufacturing Services Contract manufacturing services for pharmaceutical partners, utilizing Epic Pharma's cGMP-compliant facility, in-house analytical testing capabilities, and DEA-registered controlled substance handling.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Sandoz: Global generic pharmaceutical leader and former owner of Epic's Laurelton facility (acquired by Epic in 2008). Direct comparability in product categories, manufacturing capabilities, and therapeutic coverage.
• Sun Pharmaceutical Industries: One of the largest Indian generic manufacturers with extensive U.S. generic portfolio including controlled substances and specialty products. Direct therapeutic category overlap with Epic's portfolio.
• Aurobindo Pharma USA: U.S. subsidiary of Indian generic major Aurobindo Pharma, one of the largest generic manufacturers globally with extensive ANDA portfolio across all major therapeutic categories including controlled substances.
• Lupin Pharmaceuticals: Indian-headquartered global generic manufacturer with significant U.S. presence and overlapping portfolio in cardiovascular, CNS, and anti-infective categories. Comparable contract manufacturing service model.
• Zydus Pharmaceuticals: U.S. arm of Zydus Cadila, manufacturing generic oral solids, injectables, and specialty products. Significant overlap with Epic's cardiovascular, CNS, and anti-infective categories.
• Apotex Corp: Major Canadian-based global generic manufacturer with substantial U.S. operations. Overlapping portfolio in oral solids across multiple therapeutic categories Epic serves.

Direct peers

• Lannett Company: U.S.-based generic pharmaceutical manufacturer with a comparable focus on oral solid dosage forms and contract manufacturing. Similar mid-cap scale with diversified therapeutic portfolio and similar exposure to generic pricing pressure.
• Upsher-Smith Laboratories: Private U.S. generic pharmaceutical manufacturer focused on oral solid dose generics across similar therapeutic categories (CNS, cardiovascular). Comparable mid-sized private company profile with contract manufacturing capabilities.
• Amneal Pharmaceuticals: Generic and specialty pharmaceutical manufacturer with overlapping portfolio across CNS, cardiovascular, and anti-infectives. Operates cGMP facilities with comparable distribution model to U.S. healthcare providers.
• Granules Pharmaceuticals: Vertically integrated generic manufacturer producing finished dosage forms including controlled substances, with comparable FDA-approved U.S. manufacturing operations serving similar customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/epic-pharma

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Epic Pharma